Pages that link to "Q48282072"
Jump to navigation
Jump to search
The following pages link to Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia (Q48282072):
Displaying 50 items.
- GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. (Q24625065) (← links)
- GABA abnormalities in schizophrenia: a methodological review of in vivo studies (Q26864125) (← links)
- Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches (Q26864324) (← links)
- Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia (Q28080437) (← links)
- GABA(B) receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implications (Q30376372) (← links)
- GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders (Q30479407) (← links)
- Brain connectivity studies in schizophrenia: unravelling the effects of antipsychotics (Q30596256) (← links)
- Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation (Q30854782) (← links)
- Treatment of cognitive deficits in schizophrenia. Part 2: Pharmacological strategies (Q33535963) (← links)
- Neurocognitive profiles of learning disabled children with neurofibromatosis type 1 (Q33720679) (← links)
- Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT (Q33940105) (← links)
- Neurofibromin regulates corticostriatal inhibitory networks during working memory performance (Q34086356) (← links)
- Altered resting-state connectivity in subjects at ultra-high risk for psychosis: an fMRI study (Q34221431) (← links)
- GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study (Q34446463) (← links)
- Association of childhood trauma exposure and GABRA2 polymorphisms with risk of posttraumatic stress disorder in adults. (Q35792779) (← links)
- Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set. (Q36324947) (← links)
- A quantitative system pharmacology computer model for cognitive deficits in schizophrenia (Q36795559) (← links)
- Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia (Q36842940) (← links)
- Affect recognition deficits in schizophrenia: neural substrates and psychopharmacological implications (Q36870052) (← links)
- Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia (Q37078047) (← links)
- Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 Patients (Q37276997) (← links)
- Auditory Oddball fMRI in Schizophrenia: Association of Negative Symptoms with Regional Hypoactivation to Novel Distractors (Q37345525) (← links)
- Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia? (Q37358661) (← links)
- Pharmacological cognitive enhancement in schizophrenia (Q37511870) (← links)
- Abnormal GABAergic function and negative affect in schizophrenia. (Q37584271) (← links)
- Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge (Q37654638) (← links)
- The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline (Q37784829) (← links)
- The treatment of cognitive impairment in schizophrenia (Q37813206) (← links)
- Pharmacotherapy for treatment-refractory schizophrenia (Q37831352) (← links)
- Pharmacological Strategies for Enhancing Cognition in Schizophrenia (Q37839921) (← links)
- Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia (Q37846896) (← links)
- Can genetics inform the management of cognitive deficits in schizophrenia? (Q37983548) (← links)
- Pharmacotherapy of cognitive deficits in schizophrenia (Q38162531) (← links)
- Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What's the Evidence? (Q38173359) (← links)
- Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets (Q38187948) (← links)
- A Novel Multisensory Integration Task Reveals Robust Deficits in Rodent Models of Schizophrenia: Converging Evidence for Remediation via Nicotinic Receptor Stimulation of Inhibitory Transmission in the Prefrontal Cortex. (Q39100348) (← links)
- Prefrontal cortex executive processes affected by stress in health and disease (Q39424256) (← links)
- GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies (Q41370905) (← links)
- Of mice and men: bridging the translational disconnect in CNS drug discovery (Q42637193) (← links)
- Quetiapine and flupentixol differentially improve anterior cingulate cortex function in schizophrenia patients: an event-related potential study (Q44624785) (← links)
- Monitoring Technology for Gamma-Aminobutyric acid Production in Polished Mochi Barley Grains using a Carbon Dioxide Sensor (Q46737008) (← links)
- Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia (Q48177435) (← links)
- The involvement of GABA(A) receptor in the molecular mechanisms of combined selective serotonin reuptake inhibitor-antipsychotic treatment (Q48295240) (← links)
- Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis (Q48568331) (← links)
- Brain activity supporting working memory accuracy in patients with paranoid schizophrenia: a functional magnetic resonance imaging study (Q49131770) (← links)
- 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia. (Q49551461) (← links)
- Visuospatial working memory deficits in remitted patients with bipolar disorder: susceptibility to the effects of GABAergic agonists (Q50790547) (← links)
- Impaired temporoparietal deactivation with working memory load in antipsychotic-naïve patients with first-episode schizophrenia (Q51017971) (← links)
- Sensory and motor encoding strategies in n-back tasks: a simulation of schizophrenic working memory deficits in healthy subjects (Q51024055) (← links)
- Failure to deactivate in the prefrontal cortex in schizophrenia: dysfunction of the default mode network? (Q51890348) (← links)